Cas no 1001500-51-1 ((4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine)
(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine Chemical and Physical Properties
Names and Identifiers
-
- (4-Bromo-2-ethyl-2H-pyrazol-3-ylmethyl)-methyl-amine
- (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine
-
- MDL: MFCD04969717
- Inchi: InChI=1S/C7H12BrN3/c1-3-11-7(5-9-2)6(8)4-10-11/h4,9H,3,5H2,1-2H3
- InChI Key: GSBLMXCODQJMJH-UHFFFAOYSA-N
- SMILES: CCN1C(=C(C=N1)Br)CNC
Computed Properties
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 3
(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM483048-1g |
2-(4-Bromo-1-ethyl-1H-pyrazol-5-yl)ethanamine |
1001500-51-1 | 97% | 1g |
$734 | 2022-06-14 | |
| Enamine | EN300-229470-1g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 1g |
$743.0 | 2023-09-15 | ||
| Enamine | EN300-229470-5g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 5g |
$2152.0 | 2023-09-15 | ||
| Enamine | EN300-229470-10g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 10g |
$3191.0 | 2023-09-15 | ||
| Enamine | EN300-229470-0.05g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 0.05g |
$624.0 | 2024-06-20 | |
| Enamine | EN300-229470-0.1g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 0.1g |
$653.0 | 2024-06-20 | |
| Enamine | EN300-229470-0.25g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 0.25g |
$683.0 | 2024-06-20 | |
| Enamine | EN300-229470-0.5g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 0.5g |
$713.0 | 2024-06-20 | |
| Enamine | EN300-229470-1.0g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 1.0g |
$743.0 | 2024-06-20 | |
| Enamine | EN300-229470-2.5g |
[(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine |
1001500-51-1 | 95% | 2.5g |
$1454.0 | 2024-06-20 |
(4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine Related Literature
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
-
Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
-
Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
Additional information on (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine
Comprehensive Analysis of (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine (CAS No. 1001500-51-1)
The compound (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine, identified by its CAS No. 1001500-51-1, represents a significant area of interest in modern organic chemistry and pharmaceutical research. This pyrazole derivative is characterized by its unique structural features, including a bromine substituent and an ethyl group, which contribute to its potential applications in drug discovery and material science. Researchers are increasingly focusing on such heterocyclic compounds due to their versatility in synthesizing biologically active molecules.
One of the most frequently searched questions regarding this compound is: "What are the synthetic routes for (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine?" The synthesis typically involves multi-step reactions, starting with the bromination of pyrazole precursors, followed by N-alkylation and amine functionalization. The presence of the bromo group at the 4-position makes it a valuable intermediate for further cross-coupling reactions, such as Suzuki or Buchwald-Hartwig couplings, which are pivotal in creating complex molecular architectures.
In the context of drug discovery, this compound has garnered attention due to its potential as a pharmacophore. The pyrazole core is a common motif in many FDA-approved drugs, particularly in anti-inflammatory and anticancer agents. Users often search for "biological activity of (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine", highlighting the growing curiosity about its therapeutic potential. Preliminary studies suggest interactions with enzyme targets, though extensive in vitro and in vivo studies are needed to validate these findings.
Another trending topic is the compound's role in material science. Its electron-rich structure makes it a candidate for designing organic semiconductors or ligands in catalysis. Searches like "applications of pyrazole derivatives in OLEDs" reflect this interest. The methylamine moiety further enhances its solubility, a critical factor for processing in thin-film technologies.
From a safety and handling perspective, users frequently inquire about "storage conditions for CAS 1001500-51-1". While not classified as hazardous, standard precautions for organic compounds—such as storage in cool, dry environments away from light—are recommended. Proper personal protective equipment (PPE) should always be used during laboratory handling.
The compound's analytical characterization is another area of interest. Techniques like NMR spectroscopy, mass spectrometry, and HPLC purity analysis are essential for quality control. Queries such as "HPLC method for (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine" underscore the need for reliable analytical protocols in research and industrial settings.
In summary, (4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine (CAS 1001500-51-1) is a multifaceted compound with promising applications across pharmaceuticals, materials science, and chemical synthesis. Its structural uniqueness and functional adaptability continue to drive research, making it a subject of both academic and industrial relevance.
1001500-51-1 ((4-bromo-1-ethyl-1H-pyrazol-5-yl)methyl(methyl)amine) Related Products
- 1005577-35-4(1-(4-Bromo-2-ethyl-2H-pyrazol-3-ylmethyl)-3-butyl-thiourea)
- 1001500-52-2((4-bromo-1-methyl-1H-pyrazol-5-yl)methyl(methyl)amine)
- 51108-51-1(4-Bromo-1-ethyl-3,5-dimethyl-1H-pyrazole)
- 1171667-09-6(4-Bromo-1-ethyl-5-methyl-1H-pyrazole)
- 1263378-90-0(3-bromo-4H,5H,6H,7H-pyrazolo1,5-apyrazine)
- 1001500-50-0((4-bromo-1-ethyl-1H-pyrazol-5-yl)methanamine)
- 1184989-52-3((4-bromo-1-ethyl-1H-pyrazol-5-yl)methylamine)
- 1002651-67-3([(1-ethyl-1H-pyrazol-5-yl)methyl](methyl)amine)
- 1001500-18-0((4-Bromo-1-ethyl-1 H -pyrazol-3-ylmethyl)-methyl-amine)
- 1006471-52-8(N-[(4-bromo-1-methyl-1H-pyrazol-3-yl)methyl]-N-methylamine)